Contract awardedApheresis machines

Transfusion Technology Products - LOVO instrument – med device CE marked

Provision of ongoing maintenance and technical support for two LOVO cell processing systems. The contract covers the servicing of these specific medical devices to ensure operational continuity and compliance with technical standards for advanced therapy applications.

Awarded value
£188k
As published
Published
7 March 2025
Awarded
7 March 2025
Contract length
12 months
Ends 20 March 2026

What the contract covers

Provision of specialist maintenance and technical support services for advanced cell processing and transfusion technology medical instrumentation systems.

Terms and requirements

Procedure
Direct award
Initial term
12 months
Contract dates
21 March 2025 to 20 March 2026
Certifications asked for
None stated
Lots
1
Suitable for SMEs
Not stated
CPV codes
33100000

Services in this contract

Lifecycle

  1. Published
  2. Contract awarded
  3. Contract starts
  4. Contract ends
The buyer

Newcastle upon Tyne Hospitals NHS Foundation Trust

Type
Locked
Contracts, 24 months
Locked
Recorded value
Locked
Typical contract
Locked
Apheresis machines contracts, 24 months
Locked
Buys mostLocked
Contact details
Email
Locked
Website
Locked
Address
Locked
See everything Newcastle upon Tyne Hospitals NHS Foundation Trust buys

Similar apheresis machines contracts and prices

36 apheresis machines contracts were awarded in the last 24 months. See who won them and what they went for, next to this one.

See who won them →

Cite this contract

Link
https://bidskim.com/tender/319544/transfusion-technology-products-lovo-instrument-med-device-ce-marked
Buyer reference
C340408
Open contracting ID
ocds-h6vhtk-04ea6f
Last checked
4 November 2026

Newcastle upon Tyne Hospitals NHS Foundation Trust. Transfusion Technology Products - LOVO instrument – med device CE marked. Contract award, 7 March 2025. BidSkim, https://bidskim.com/tender/319544/transfusion-technology-products-lovo-instrument-med-device-ce-marked (accessed 4 November 2026).